NO924954L - Trykkpaalagte aerosolsammensetninger - Google Patents

Trykkpaalagte aerosolsammensetninger

Info

Publication number
NO924954L
NO924954L NO92924954A NO924954A NO924954L NO 924954 L NO924954 L NO 924954L NO 92924954 A NO92924954 A NO 92924954A NO 924954 A NO924954 A NO 924954A NO 924954 L NO924954 L NO 924954L
Authority
NO
Norway
Prior art keywords
pressure
aerosol compositions
surfactant
propellant
prepared aerosol
Prior art date
Application number
NO92924954A
Other languages
English (en)
Norwegian (no)
Other versions
NO924954D0 (no
Inventor
Asit Somani
Clive Booles
Original Assignee
Fisons Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB909014526A external-priority patent/GB9014526D0/en
Priority claimed from GB909014527A external-priority patent/GB9014527D0/en
Priority claimed from GB909023953A external-priority patent/GB9023953D0/en
Application filed by Fisons Plc filed Critical Fisons Plc
Publication of NO924954D0 publication Critical patent/NO924954D0/no
Publication of NO924954L publication Critical patent/NO924954L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/008—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy comprising drug dissolved or suspended in liquid propellant for inhalation via a pressurized metered dose inhaler [MDI]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/12—Aerosols; Foams
    • A61K9/124—Aerosols; Foams characterised by the propellant

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dispersion Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Otolaryngology (AREA)
  • Pulmonology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cosmetics (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Containers And Packaging Bodies Having A Special Means To Remove Contents (AREA)
  • Fertilizers (AREA)
NO92924954A 1990-06-29 1992-12-21 Trykkpaalagte aerosolsammensetninger NO924954L (no)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
GB909014526A GB9014526D0 (en) 1990-06-29 1990-06-29 Aerosol formulation
GB909014527A GB9014527D0 (en) 1990-06-29 1990-06-29 Aerosol formulation
GB909023953A GB9023953D0 (en) 1990-11-03 1990-11-03 Pharmaceutical composition
PCT/GB1991/001023 WO1992000061A1 (en) 1990-06-29 1991-06-25 Pressurised aerosol compositions

Publications (2)

Publication Number Publication Date
NO924954D0 NO924954D0 (no) 1992-12-21
NO924954L true NO924954L (no) 1992-12-21

Family

ID=27265168

Family Applications (1)

Application Number Title Priority Date Filing Date
NO92924954A NO924954L (no) 1990-06-29 1992-12-21 Trykkpaalagte aerosolsammensetninger

Country Status (21)

Country Link
US (1) US5846521A (de)
EP (1) EP0536235B1 (de)
JP (1) JP2854974B2 (de)
AT (1) ATE147973T1 (de)
AU (1) AU8055691A (de)
BR (1) BR9106595A (de)
CA (1) CA2085884C (de)
CZ (1) CZ392592A3 (de)
DE (1) DE69124374T2 (de)
DK (1) DK0536235T3 (de)
ES (1) ES2096653T3 (de)
FI (1) FI925852L (de)
GR (1) GR3023065T3 (de)
HU (1) HUT63554A (de)
IE (1) IE912220A1 (de)
MX (1) MX9100008A (de)
NO (1) NO924954L (de)
NZ (1) NZ238746A (de)
PT (1) PT98133A (de)
SK (1) SK392592A3 (de)
WO (1) WO1992000061A1 (de)

Families Citing this family (56)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5766573A (en) * 1988-12-06 1998-06-16 Riker Laboratories, Inc. Medicinal aerosol formulations
US5225183A (en) * 1988-12-06 1993-07-06 Riker Laboratories, Inc. Medicinal aerosol formulations
US5785952A (en) * 1990-11-09 1998-07-28 Glaxo Group Limited Aerosol medicament formulation having a surface coating of surfactant
ATE246497T1 (de) * 1991-06-10 2003-08-15 Schering Corp Fluorchlorkohlenwasserstoffreie aerosolformulierungen
FI935463A7 (fi) 1991-06-10 1993-12-07 Schering Corp Kloorifluorihiilettömät aerosoliformulaatiot
ES2123576T3 (es) 1991-12-12 1999-01-16 Glaxo Group Ltd Medicamentos.
US5916540A (en) 1994-10-24 1999-06-29 Glaxo Group Limited Aerosol formulations containing P134A and/or P227 and particulate medicament
IL104068A (en) * 1991-12-12 1998-10-30 Glaxo Group Ltd Surfactant-free pharmaceutical aerosol formulation comprising 1,1,1,2-tetrafluoroethane or 1,1,1,2,3,3,3-heptafluoro-n- propane as propellant
US7105152B1 (en) 1991-12-18 2006-09-12 3M Innovative Properties Company Suspension aerosol formulations
US7101534B1 (en) 1991-12-18 2006-09-05 3M Innovative Properties Company Suspension aerosol formulations
US5376359A (en) * 1992-07-07 1994-12-27 Glaxo, Inc. Method of stabilizing aerosol formulations
MX9304585A (es) * 1992-07-31 1994-03-31 Glaxo Group Ltd Formulacion farmaceutica en aerosol, lata adecuada para liberar la formulacion e inhalador de dosis dosificada que comprende la lata.
JPH08507792A (ja) * 1993-03-17 1996-08-20 ミネソタ マイニング アンド マニュファクチャリング カンパニー ジオール−二酸から誘導される分散助剤を含むエーロゾル配合物
KR100321649B1 (ko) * 1993-03-17 2002-07-22 미네소타 마이닝 앤드 매뉴팩춰링 캄파니 에스테르,아미드또는머캅토에스테르로부터유도된분산보조제를함유하는에어로졸제제
US5593661A (en) * 1993-03-29 1997-01-14 Henry; Richard A. Lidocaine aerosol anaesthetic
WO1995015151A1 (en) * 1993-12-02 1995-06-08 Abbott Laboratories Aerosol drug formulations for use with non-cfc propellants
US5502076A (en) * 1994-03-08 1996-03-26 Hoffmann-La Roche Inc. Dispersing agents for use with hydrofluoroalkane propellants
US5635159A (en) * 1994-08-26 1997-06-03 Abbott Laboratories Aerosol drug formulations containing polyglycolyzed glycerides
US5635161A (en) * 1995-06-07 1997-06-03 Abbott Laboratories Aerosol drug formulations containing vegetable oils
US20020052310A1 (en) 1997-09-15 2002-05-02 Massachusetts Institute Of Technology The Penn State Research Foundation Particles for inhalation having sustained release properties
US6652837B1 (en) 1996-05-24 2003-11-25 Massachusetts Institute Of Technology Preparation of novel particles for inhalation
US5874064A (en) 1996-05-24 1999-02-23 Massachusetts Institute Of Technology Aerodynamically light particles for pulmonary drug delivery
GB9616237D0 (en) 1996-08-01 1996-09-11 Norton Healthcare Ltd Aerosol formulations
WO1998034595A1 (de) 1997-02-05 1998-08-13 Jago Research Ag Medizinische aerosolformulierungen
US7052678B2 (en) 1997-09-15 2006-05-30 Massachusetts Institute Of Technology Particles for inhalation having sustained release properties
US6309623B1 (en) 1997-09-29 2001-10-30 Inhale Therapeutic Systems, Inc. Stabilized preparations for use in metered dose inhalers
US6946117B1 (en) 1997-09-29 2005-09-20 Nektar Therapeutics Stabilized preparations for use in nebulizers
US6433040B1 (en) 1997-09-29 2002-08-13 Inhale Therapeutic Systems, Inc. Stabilized bioactive preparations and methods of use
US6565885B1 (en) 1997-09-29 2003-05-20 Inhale Therapeutic Systems, Inc. Methods of spray drying pharmaceutical compositions
US20060165606A1 (en) 1997-09-29 2006-07-27 Nektar Therapeutics Pulmonary delivery particles comprising water insoluble or crystalline active agents
GB9805938D0 (en) 1998-03-19 1998-05-13 Glaxo Group Ltd Valve for aerosol container
GB9807232D0 (en) 1998-04-03 1998-06-03 Univ Cardiff Aerosol composition
US6451285B2 (en) 1998-06-19 2002-09-17 Baker Norton Pharmaceuticals, Inc. Suspension aerosol formulations containing formoterol fumarate and a fluoroalkane propellant
AU748867B2 (en) 1998-07-24 2002-06-13 Jagotec Ag Medicinal aerosol formulations
CA2338680C (en) 1998-08-04 2008-10-14 Jago Research Ag Medicinal aerosol formulations
US6956021B1 (en) 1998-08-25 2005-10-18 Advanced Inhalation Research, Inc. Stable spray-dried protein formulations
US6749835B1 (en) 1999-08-25 2004-06-15 Advanced Inhalation Research, Inc. Formulation for spray-drying large porous particles
US7678364B2 (en) 1999-08-25 2010-03-16 Alkermes, Inc. Particles for inhalation having sustained release properties
US7871598B1 (en) 2000-05-10 2011-01-18 Novartis Ag Stable metal ion-lipid powdered pharmaceutical compositions for drug delivery and methods of use
US8404217B2 (en) 2000-05-10 2013-03-26 Novartis Ag Formulation for pulmonary administration of antifungal agents, and associated methods of manufacture and use
US6451287B1 (en) 2000-05-26 2002-09-17 Smithkline Beecham Corporation Fluorinated copolymer surfactants and use thereof in aerosol compositions
US7217409B2 (en) 2000-09-22 2007-05-15 Smithkline Beecham Corporation Alkanoic acid derivatives
WO2002053190A2 (en) 2000-12-29 2002-07-11 Advanced Inhalation Research, Inc. Particles for inhalation having sustained release properties
GB0208742D0 (en) 2002-04-17 2002-05-29 Bradford Particle Design Ltd Particulate materials
GB0125127D0 (en) 2001-10-19 2001-12-12 Glaxo Group Ltd Compounds
PT1455755E (pt) 2001-11-20 2013-06-18 Civitas Therapeutics Inc Composições particuladas melhoradas para distribuição pulmonar
WO2003053411A1 (en) 2001-12-19 2003-07-03 Nektar Therapeutics Pulmonary delivery of aminoglycosides
US7718162B2 (en) * 2001-12-21 2010-05-18 3M Innovative Properties Company Medicinal aerosol compositions with a functionalized polyethyleneglycol excipient
MXPA04007899A (es) 2002-02-13 2004-10-15 Glaxo Group Ltd Compuestos de acido carboxilico para usarse como agentes tensoactivos.
GB0205327D0 (en) * 2002-03-06 2002-04-17 Glaxo Group Ltd compounds
US7582284B2 (en) 2002-04-17 2009-09-01 Nektar Therapeutics Particulate materials
EP2275479A1 (de) 2003-08-11 2011-01-19 Glaxo Group Limited Pharmazeutuscher Dosierinhalator und zugehörige Verfahren
ES2668780T3 (es) 2003-08-29 2018-05-22 Glaxo Group Limited Inhalador de dosificación farmacéutica medida y procedimientos relacionados con el mismo
ES2538082T3 (es) 2007-02-11 2015-06-17 Map Pharmaceuticals Inc Método de administración terapéutica de DHE para permitir el rápido alivio de migraña mientras que se minimiza el perfil de efectos secundarios
GB0712454D0 (en) 2007-06-27 2007-08-08 Generics Uk Ltd Pharmaceutical compositions
WO2016018892A1 (en) 2014-07-29 2016-02-04 3M Innovative Properties Company Method of preparing a pharmaceutical composition

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL7708731A (nl) * 1976-08-13 1978-02-15 Montedison Spa Werkwijze voor de bereiding van nieuwe drijf- middelsamenstellingen voor aerosolen.
CA1136547A (en) * 1979-03-08 1982-11-30 Song-Ling Lin Aerosol anesthetic compositions
GB8432063D0 (en) * 1984-12-19 1985-01-30 Riker Laboratories Inc Physically modified steroids
JP2770970B2 (ja) * 1987-04-09 1998-07-02 フアイソンズ・ピーエルシー ペンタミジンを含有する医薬組成物
US5225183A (en) * 1988-12-06 1993-07-06 Riker Laboratories, Inc. Medicinal aerosol formulations
GB8828477D0 (en) * 1988-12-06 1989-01-05 Riker Laboratories Inc Medical aerosol formulations
GB8828544D0 (en) * 1988-12-07 1989-01-11 Ici Plc Chemical process
DE3905726A1 (de) * 1989-02-24 1990-08-30 Hoechst Ag Druckgaspackung und treibmittel fuer aerosole
GB8908250D0 (en) * 1989-04-12 1989-05-24 Fisons Plc Formulations
US5683676A (en) * 1991-12-12 1997-11-04 Glaxo Group Limited Canister containing aerosol formulations containing P134a and particulate medicaments
US5658549A (en) * 1991-12-12 1997-08-19 Glaxo Group Limited Aerosol formulations containing propellant 134a and fluticasone propionate

Also Published As

Publication number Publication date
WO1992000061A1 (en) 1992-01-09
MX9100008A (es) 1992-02-03
CA2085884A1 (en) 1991-12-30
HUT63554A (en) 1993-09-28
ATE147973T1 (de) 1997-02-15
DE69124374T2 (de) 1997-06-19
EP0536235B1 (de) 1997-01-22
US5846521A (en) 1998-12-08
FI925852A7 (fi) 1992-12-23
JPH05507712A (ja) 1993-11-04
PT98133A (pt) 1992-04-30
NO924954D0 (no) 1992-12-21
JP2854974B2 (ja) 1999-02-10
HU9204098D0 (en) 1993-03-29
CZ392592A3 (en) 1993-05-12
BR9106595A (pt) 1993-04-20
DK0536235T3 (da) 1997-04-14
GR3023065T3 (en) 1997-07-30
IE912220A1 (en) 1992-01-01
ES2096653T3 (es) 1997-03-16
DE69124374D1 (de) 1997-03-06
NZ238746A (en) 1992-10-28
SK392592A3 (en) 1994-07-06
CA2085884C (en) 2001-12-04
FI925852A0 (fi) 1992-12-23
AU8055691A (en) 1992-01-23
FI925852L (fi) 1992-12-23
EP0536235A1 (de) 1993-04-14

Similar Documents

Publication Publication Date Title
NO924954D0 (no) Trykkpaalagte aerosolsammensetninger
DK0513127T3 (da) Drivmiddelpræparater
DE69711637D1 (de) Aerosolformulierungen
GR3025958T3 (en) Sulfonylalkanoylamino hydroxyethylamino sulfonamides useful as retroviral protease inhibitors.
ES2098444T3 (es) Composiciones refrigerantes.
UA27143C2 (uk) Рідка фармацевтичhа композиція в формі аерозолю
MY110232A (en) Binary azeotropic compositions of (cf3chfchfch2cf3) with methanol or ethanol or isopropanol.
ES2145254T3 (es) Formulaciones de aerosoles que contienen flunisolida.
DE69223322D1 (de) Haarspraypraeparate
YU48509B (sh) Suspenzije u kondenzovanim potisnim gasovima
KR950702959A (ko) 레트로바이러스 프로테아제 저해제로서 유용한 n--술폰아미드(n-(alkanoylamino-2-hydroxypropyl)-sulfonamides useful as retorviral protease inhibitors)
NO974104L (no) Faste diacyl-organiske peroksyd-dispersjoner
DE69726457D1 (de) Pharmazeutische zusammensetzungen mit antimikrobieller wirkung
BR9702102A (pt) Dispositivo pressurizado
ES2071984T3 (es) Composiciones azeotropicas de perfluoro-1,2-dimetilciclobutano con 1,1-dicloro-1-fluoroetano.
GR1001067B (el) Νέες κτηνιατρικές και προστι?έμενες συν?έσεις προστασίας φυτών.
JPS51116185A (en) An aerosol composition
PT666755E (pt) Inibicao da infeccao pelo vih
RU92016480A (ru) Аэрозольные композиции, содержащие лекарственный препарат
ES2091008T3 (es) Agente para el cuidado del cabello.
JPS5432634A (en) Medicines for peptic ulcer
ES2163142T3 (es) Nuevos peptidos y agente neotropico.